Following a caution from the Supreme Court regarding potentially misleading claims in their advertisements, Patanjali Ayurved asserted its commitment to truthfulness. The company stated that it possesses a substantial database, including real-world evidence, preclinical and clinical data, supporting its products.
Patanjali, led by Baba Ramdev, clarified that it is not engaging in false propaganda and expressed a willingness to accept any consequences, including fines or even a “death sentence,” if found guilty of misleading advertising. In a press conference in Haridwar, Ramdev emphasized the company’s respect for the court and reiterated his commitment to presenting facts, clinical evidence, and scientific research papers in support of their claims.
The Supreme Court had cautioned Patanjali on the 23rd of August, 2022, following a plea from the Indian Medical Association (IMA), which accused Ramdev of conducting a smear campaign against vaccinations and modern medicines.
Patanjali defended its stance, asserting that its therapies, including Yoga, Ayurveda, Naturopathy, Panchakarma, and Shatkarma, have successfully treated numerous individuals suffering from various diseases. The company highlighted its research center, Patanjali Research Foundation, where renowned scientists conduct research, resulting in the publication of nearly 500 research papers in reputable journals.
In response to allegations from certain doctors opposing alternative medical practices, Patanjali argued that it has successfully addressed health issues through holistic approaches. The company acknowledged the role of synthetic medicines in controlling diseases but claimed that allopathy falls short in providing complete cures.
While reaffirming their commitment to traditional healing methods, Patanjali also criticized malpractices within the medical field, referring to them as “medical crimes” and emphasizing their efforts against such practices.